Standards of statin usage in Poland in high-risk patients: 3ST-POL study results

Kardiologia Polska

Volumn 71, Issue 3, 2013, Pages 253-259

  Śliz, Daniel ^a   Filipiak, Krzysztof J ^a   Naruszwicz, Marek ^a   Siebert, Janusz ^b   Mamcarz, Artur ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Hypercholesterolaemia; Pharmacotherapy; Statin

Indexed keywords

ATORVASTATIN; CHOLESTEROL; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN;

ADULT; AGED; ARTICLE; CARDIOLOGIST; CHOLESTEROL BLOOD LEVEL; DIABETOLOGIST; DISEASE DURATION; DRUG USE; DYSLIPIDEMIA; FEMALE; GENERAL PRACTITIONER; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PHYSICIAN; POLAND; TREATMENT DURATION; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

EID: 84875654023     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: 10.5603/KP.2013.0037     Document Type: Article

References (16)

1. http://www.who.int/mediacentre/factsheets/fs310/en/index.html (visit: 14-10-2011).
2. Ogólnopolskie i regionalne rozpowszechnienie głó wnych czynników ryzyka układu sercowo-naczyniowego. Wyniki ogólnopolskiego badania stanu zdrowia ludności. Program WOBASZ. Kardiol Pol, 2005; 63 (suppl. 4): 614-685.
3. Broda G, Rywik S. Wieloośrodkowe ogólnopolskie badanie zdrowia ludności-projekt WOBASZ. Zdefiniowanie problemu oraz cele badania. Kardiol Pol, 2005; 63 (suppl. 4): 601-4.
4. Zdrojewski T, Bandosz P, Szpakowski P et al. Rozpowszechnienie głównych czynników ryzyka chorób układu sercowo-naczyniowego w Polsce. Wyniki badania NATPOL PLUS. Kardiol Pol, 2004; 61 (supl. IV): 1-26.
5. Graham I, Atar D, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice: fourth Joint Task Force of the European Society of Cardiology and other societies. Eur J Cardiovasc Prev Rehabil, 2007; 14 (suppl. 2): S1-S113.
6. Task Force Members; ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J, 2011; 32: 1769-1818.
7. Sliz D, Mamcarz A, Filipiak KJ et al. 3ST-POL trial: standards of statin use in Poland in the context of the European Society of Cardiology guidelines. Pol Arch Med Wewn, 2010; 120: 328-333.
8. Conroy RM, Pyörälä K, Fitzgerald AP et al.; on behalf of the SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J, 2003; 24: 987-100.
9. Phataka H, Wentworthb C, Sazonova V et al. Prevalence and predictors of lipid abnormalities in patients treated with statins in the UK general practice. Atherosclerosis, 2009; 202: 225-233.
10. Böhler S, Scharnagl H, Freisinger F et al. Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany. Atherosclerosis, 2007; 190: 397-407.
11. Gitt AK, Jünger C, Smolka W. Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany. Clin Res Cardiol, 2010; 99: 723-733.
12. Pietrasik A, Starczewska ME, Główczyńska R et al. Leczenie choroby wieńcowej-polska rzeczywistość w świetle wyników badania POLKARD-SPOK. Przeg Lek, 2005; 6: 52-57.
13. Kotseva K, Wood D, De Backer G et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. J Cardiovasc Risk, 2009; 16: 121-137.
14. Penning-van Beest FJ, Termorshuizen F, Goettsch WG et al. Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40%: a cohort study. Eur Heart J, 2007; 28: 154-159.
15. Korhonen MJ, Helin-Salmivaara A, Huupponen R. Dynamics of long-term statin therapy. Eur J Clin Pharmacol, 2011; 67: 925-931.
16. Shakur R, Sathasivam S, Yu C et al. Optimizing secondary prevention: Statin prescribing across East and West London in accordance with NICE guidelines. JRSM Short Rep, 2011; 2: 63-69.